Vertex Announces Plan to Expand Cell and Gene Therapy Footprint

Excerpt Vertex Pharmaceuticals Incorporated has announced plans to set up another 344,000 sq ft facility in the Seaport to support the company’s continued rapid growth of its cell and genetic therapies programs. Article Summary The completion of the new site at Seaport is expected in 2025 following which Vertex will occupy 1.9 million square feet […]

Ultragenyx Acquires AAV gene therapy from Abeona Therapeutics Inc

Excerpt US based Biopharma Company, Ultragenyx has announced the acquisition AAV Gene Therapy (ABO-102) for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics. Article Summary ABO-102 (now UX111), is a novel gene therapy in Phase 1/2 development for Sanfilippo syndrome type A (MPS IIIA), a rare lysosomal storage disease with no approved treatment that […]

Transforming Cancer Treatment with Revolutionary CART – Cell Therapy – Story of Emily Whitehead Being Cancer Free

Article Summary In 2012, Emily Whitehead was diagnosed with acute lymphoblastic leukemia (ALL). After two years of unsuccessful chemotherapy and rapidly declining health, Emily became the first pediatric patient in the world to receive CAR T-cell therapy product called tisagenlecleucel or Kymriah and the first patient of any age to receive it for ALL. In […]

Avantor to Create a New Manufacturing and Distribution Hub in Singapore

Excerpt: Advanced technologies and applied materials provider, Avantor has announced the development of its new manufacturing and distribution hub in Singapore by integrating its existing distribution facility with new manufacturing operations.  Article Summary With the establishment of this new hub, Avantor aims to bring its solutions closer to regional customers and strengthens global supply chain […]

Akron Bio Expands Commercialization of Gene Therapy and Vaccine Production with New Manufacturing Facility

Excerpt: Akron Bio has launched a new, state-of-the-art cGMP plasmid DNA manufacturing facility in Sarasota, Florida to address critical demands in the rapidly growing gene therapy and vaccine markets. Article Summary Through the new facility, Akron Bio will provide plasmid DNA, critical material used in the production of advanced therapies. The new site will support […]

Be Bio Closes $130 Million Financing to Advance Engineered B Cells Platforms

Excerpt: Be Biopharma, cell therapy developer of Engineered B Cell Medicines (BeCM), has announced the closing of a $130 million financing, bringing the total investment in the Company to over $180 million. Proceeds will advance autologous and allogeneic Engineered B Cell Medicine (BeCM) platforms, as well as progress pipeline candidates in oncology and rare disease […]

Juniper Biologics Acquired Cell-Mediated Gene Therapy TG-C LD For Knee Osteoarthritis

Excerpt: Juniper Biologics has obtained the licensing rights for the development and commercialisation of Kolon Life Science’s cell-mediated gene therapy, TissueGene-C low dose (TG-C LD), to treat knee osteoarthritis. Juniper will develop and market TG-C LD in the Asia Pacific, the Middle East and Africa under the $600m licensing deal. Article Summary A non-surgical investigational […]

Lysogene and Yeda Signs Gene Therapy Licensing Deal

Excerpt: Lysogene has signed an exclusive global licence agreement with Yeda Research and Development, the commercial arm of Weizmann Institute of Science to develop and market a gene therapy candidate to treat neuronopathic Gaucher disease and Parkinson’s disease (PD) with GBA1 mutations. Article Summary The new candidate is an adeno-associated virus (AAV) gene therapy approach […]

Supply chain integrity the focus of newly launched Thermo Fisher services for CGT sector

Excerpt: Thermo Fisher Scientific says it is leveraging the company’s global infrastructure to offer end-to-end services aimed at speeding up the introduction of cell and gene therapies. Article Summary: The organization notes that a large number of cell and gene therapies are expected to reach commercialization in the next few years. Like with any biologic, […]

Singapore and Asia’s leading BioPharma Map the Future and Catalyze Recovery for the Biomanufacturing Industry

Singapore, 31st March 2022 – The 9th Annual Biologics Manufacturing Asia 2022 & the 6th Annual BioLogistics World Asia 2022 conferences kicks off with Industry views on post pandemic biomanufacturing and a focus on the future of Asia’s Bioprocessing sector. The annual event gathered biologics and vaccine experts from all over the world at Suntec […]

Novartis Signs Initial Agreement with Carisma Therapeutics for the Manufacturing of HER 2 Targeted CAR-M Cell Therapy

Excerpt Novartis has signed an initial agreement with Carisma Therapeutics (a biopharmaceutical company focusing on engineered macrophage-based therapeutics) to manufacture the HER 2 targeted CAR-M cell therapy, which is tested in initial trials for the treatment of solid tumors. Article Summary Under the terms of the agreement, the Carisma Therapeutics manufacturing process will be transferred […]

UCB to Build Gene Therapy Process Development and Clinical Manufacturing Facility in Belgium

Excerpt UCB has announced the construction of a sustainable gene therapy process development and clinical manufacturing facility on their high-tech campus in Braine l’Alleud, Wallonia, Belgium. The company has plans to invest more than 200 million euros in the facility over the coming years. The facility is expected to be operational in 2024 while its […]